Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02114164 · ClinicalTrials.gov registry record · NA

Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies

A NA study of Prostate Cancer and Pneumoperitoneum, sponsored by OhioHealth.

Completed
Registry status
NA
Development phase
109
Enrollment target
1
Study location

NCT02114164 is a NA study of Prostate Cancer and Pneumoperitoneum that has completed, run by OhioHealth. The registered enrollment target is 109 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02114164, a NA study of Prostate Cancer and Pneumoperitoneum, has completed, sponsored by OhioHealth.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

Interventions

  • DEVICE AirSeal System
  • DEVICE Standard Endopath

Study Locations (1)

Ohio

  • Dublin Methodist Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2016-08
Est. Completion 2019-07-15
Phase NA

Sponsor

OhioHealth

20 total trials

What the Registry Record Tells You About NCT02114164

The ClinicalTrials.gov registry entry for NCT02114164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (82% lower). The listed sponsor is OhioHealth, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which AirSeal System is the first listed.

NCT02114164 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02114164 about?

NCT02114164 is a clinical study titled "Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies". The AirSeal® System will allow for lower carbon dioxide (CO2) absorption rates than the standard Endopath System.

What is the current status of trial NCT02114164?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2016-08. Estimated completion is 2019-07-15.

What conditions does trial NCT02114164 study?

This clinical trial studies the following conditions: Prostate Cancer, Pneumoperitoneum.

What interventions are being tested in trial NCT02114164?

The interventions under investigation include: AirSeal System (DEVICE), Standard Endopath (DEVICE).

Who is sponsoring clinical trial NCT02114164?

This trial is sponsored by OhioHealth, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02114164 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.